feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

AFCAT application closes today

trending

SUV drives on Dimapur tracks

trending

Madhuri Dixit in Mrs Deshpande

trending

Infosys ADR trading halted

trending

India vs South Africa T20I

trending

Netflix's Bansal Murders crime thriller

trending

India's 5 Trillion Target Delayed

trending

Jake Paul vs Anthony Joshua

trending

Kannur Warriors win SLK title

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Business and Economy / Tsuruha Holdings: Short Sellers Beware!

Tsuruha Holdings: Short Sellers Beware!

19 Dec

•

Summary

  • Tsuruha Holdings is Japan's most shorted stock, with 24.9% short interest.
  • A tender offer by Aeon is driving a significant rally in Tsuruha shares.
  • Analysts warn of a potential short squeeze if earnings surprise positively.
Tsuruha Holdings: Short Sellers Beware!

Tsuruha Holdings Inc. has become a focal point for short sellers in Japan, with 24.9% of its free float subject to short interest as of Thursday. This strategy anticipates a decline following a substantial rally that has seen the drug store operator's shares climb approximately 60% this year, reaching ¥2,800. The current surge is largely attributed to a tender offer from Aeon Co., which plans to raise its stake in Tsuruha.

Aeon's ongoing tender offer at ¥2,900 per share, a premium to recent averages, is expected to boost its ownership to over 50%. This tender offer is set to conclude just before Tsuruha is scheduled to report its earnings. Analysts suggest that if Tsuruha's financial results exceed expectations, it could ignite a short squeeze, compelling investors who bet against the stock to buy shares rapidly, thus amplifying any upward price movement.

Despite the high short interest, some market observers believe a significant short squeeze is unlikely. They point to anticipated weak earnings, potentially exacerbated by strained China-Japan relations impacting inbound tourism and retail sales. This view suggests that market participants already anticipate limited positive surprises from Tsuruha's upcoming financial disclosures.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
As of Thursday, Tsuruha Holdings had a short interest of 24.9% of its free float, making it one of Japan's most heavily shorted stocks.
Aeon is conducting a tender offer to increase its stake in Tsuruha Holdings, aiming to raise its ownership to over 50%.
Analysts warn that positive earnings from Tsuruha Holdings could lead to a short squeeze, forcing short sellers to buy back shares at higher prices.

Read more news on

Business and Economyside-arrow

You may also like

EV Charging Revolution: 5-Minute Charge Unveiled

5 Dec • 58 reads

article image

Info Edge Boosts Subsidiaries With ₹75 Crore Infusion

26 Nov • 76 reads

article image

BigBear.ai Soars on Malaysia Aerospace Deal

25 Nov • 87 reads

article image

Carlyle Launches $300M India Fund for Tech & Health

23 Nov • 135 reads

article image

GeneDx Surges 52% in Q3, Raises Full-Year Guidance

17 Nov • 137 reads

article image